This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Kappa-type opioid receptor.
Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling contributes to the inhibition of adenylate cyclase activity.
Human | |
---|---|
Gene Name: | OPRK1 |
Uniprot: | P41145 |
Entrez: | 4986 |
Belongs to: |
---|
G-protein coupled receptor 1 family |
kappa opioid receptor; kappa-type opioid receptor; KOR; K-OR-1; KOR-1; Opiate receptor, kappa-1; opioid receptor, kappa 1; OPRK; OPRK1; Oprk2; R21
Mass (kDA):
42.645 kDA
Human | |
---|---|
Location: | 8q11.23 |
Sequence: | 8; NC_000008.11 (53225716..53251697, complement) |
Detected in brain and placenta.
Cell membrane; Multi-pass membrane protein.
PMID: 8060324 by Mansson E., et al. Isolation of a human kappa opioid receptor cDNA from placenta.
PMID: 7624359 by Simonin F., et al. Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system.